Tellado, M.; De Robertis, M.; Montagna, D.; Giovannini, D.; Salgado, S.; Michinski, S.; Signori, E.; Maglietti, F.
Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III–IV Canine Oral Malignant Melanoma. Vaccines 2023, 11, 1033.
https://doi.org/10.3390/vaccines11061033
AMA Style
Tellado M, De Robertis M, Montagna D, Giovannini D, Salgado S, Michinski S, Signori E, Maglietti F.
Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III–IV Canine Oral Malignant Melanoma. Vaccines. 2023; 11(6):1033.
https://doi.org/10.3390/vaccines11061033
Chicago/Turabian Style
Tellado, MatÃas, Mariangela De Robertis, Daniela Montagna, Daniela Giovannini, Sergio Salgado, Sebastián Michinski, Emanuela Signori, and Felipe Maglietti.
2023. "Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III–IV Canine Oral Malignant Melanoma" Vaccines 11, no. 6: 1033.
https://doi.org/10.3390/vaccines11061033
APA Style
Tellado, M., De Robertis, M., Montagna, D., Giovannini, D., Salgado, S., Michinski, S., Signori, E., & Maglietti, F.
(2023). Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III–IV Canine Oral Malignant Melanoma. Vaccines, 11(6), 1033.
https://doi.org/10.3390/vaccines11061033
